MDCG 2023 3 Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices, 02/23 Anastasija Eschricht2023-03-21T12:58:10+00:00March 21st, 2023|
EMA Questions and Answers: GMP Guide Part I Chapter 8 Anastasija Eschricht2023-03-16T14:11:07+00:00March 16th, 2023|
FDA GFI, Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers, DRAFT, 12/22 Anastasija Eschricht2023-02-24T09:20:24+00:00February 24th, 2023|
MDCG 2022 21 Guidance on PSUR According to (EU) 2017/745 (MDR), 12/22 Anastasija Eschricht2023-02-24T09:00:39+00:00February 24th, 2023|
FDA GFI, Biological Product Deviation Reporting, Biological Products Other than Blood and Blood Components, 10/06 Beatrice Burtsov2022-11-09T10:18:38+00:00November 9th, 2022|
FDA GFI, Biological Product Deviation Reporting for Blood and Plasma Establishments, 03/20 Beatrice Burtsov2022-11-09T10:15:44+00:00November 9th, 2022|